Sponsored by

NovoCure Trial

Please click on the above banner for more details

WEBSITECHANGES

You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.

Click HERE for details on RSS.

Displaying items 4201 to 4225 of about 5940

Previous 25

Website Changes

11/22/2006

Increased expression of 5-lipoxygenase in high-grade astrocytomas.

11/22/2006

Cotreatment with a novel phosphoinositide analogue inhibitor and carmustine enhances chemotherapeutic efficacy by attenuating AKT activity in gliomas.

11/22/2006

Linear accelerator radiosurgery for pituitary macroadenomas: a 7-year follow-up study.

11/22/2006

Phase II trial of lomustine plus temozolomide chemotherapy in addition to radiotherapy in newly diagnosed glioblastoma: UKT-03.

11/22/2006

Initial experiences of palliative stereotactic radiosurgery for recurrent brain lymphomas.

11/22/2006

Visual field preservation after multisession cyberknife radiosurgery for perioptic lesions.

11/22/2006

Phase III trial of carmustine and cisplatin compared with carmustine alone and standard radiation therapy or accelerated radiation therapy in patients with glioblastoma multiforme: North Central Cancer Treatment Group 93-72-52 and Southwest Oncology Group 9503 Trials.

11/22/2006

The impact of thrombocytopenia from temozolomide and radiation in newly diagnosed adults with high-grade gliomas

11/22/2006

The relationship between six-month progression-free survival and 12-month overall survival end points for phase II trials in patients with glioblastoma multiforme

11/22/2006

Phase II study of Cloretazine for the treatment of adults with recurrent glioblastoma multiforme

11/22/2006

Convection-enhanced delivery of a topoisomerase I inhibitor (nanoliposomal topotecan) and a topoisomerase II inhibitor (pegylated liposomal doxorubicin) in intracranial brain tumor xenografts

11/22/2006

The course of neurocognitive functioning in high-grade glioma patients

11/22/2006

Levels and distribution of BCNU in GBM tumors following intratumoral injection of DTI-015 (BCNU-ethanol)

11/22/2006

The pathophysiologic mechanism of cerebellar mutism.

11/21/2006

University Evaluates New Device To Treat Brain Tumors

11/20/2006

Gliadel(R) Wafer Clinical Data Presented at Society for Neuro-Oncology Meeting

11/20/2006

NEOPHARM AnNOUNCES Presentation of FINAL SAFETY DATA FROM PHASE 1 TRIAL OF CINTREDEKIN BESUDOTOX for Newly Diagnosed Malignant Glioma

11/19/2006

Celtic Pharma and Neurobiological Technologies Present an Update on XERECEPT(R) for Peritumoral Brain Edema at the 11th Annual Meeting of the Society For Neuro-Oncology

11/18/2006

Mayo Clinic Cancer Center -- Harnessing the Measles Virus to Attack Cancer

11/18/2006

NCI Best Case Series for CAM: Outcomes in Treatment of Brain Tumors

11/18/2006

Vaccine for brain tumors shows promising results

11/10/2006

Reata Announces Presentation of Interim Results for Phase 1 Study of RTA 744 in Treatment of Advanced Brain Tumors

11/10/2006

Anti-cancer virus kills brain cancer cells

11/10/2006

Jefferson Oncologists Show Less Radiation Just as Effective in Fighting Brain Tumor, Saving Hearing

11/10/2006

A lesson in Living

Our privacy / cookie policy has changed.
Click HERE to read it!